Low-dose ketamine for sickle cell pain crisis
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests whether a low dose of ketamine, a pain medicine, can safely reduce pain during a sickle cell crisis in the emergency department. It aims to provide quicker pain relief for people with sickle cell disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (any type)
- You are currently having a pain crisis (vaso-occlusive crisis)
- You come to the emergency department for this pain
- You must give permission to join the study
- You cannot be pregnant
- You cannot have used ketamine in the last 24 hours
- You cannot have other serious conditions like fever, acute chest syndrome, stroke, or injury causing pain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
This trial tests whether a numbing medicine (lidocaine) given through a vein can help reduce the amount of strong painkillers (morphine or oxycodone) needed for a sickle cell pain crisis or acute chest syndrome. It aims to ease pain and possibly lower side effects from opioids.
This trial looks at the best time to start giving ketamine, a pain-relieving medicine, for sickle cell pain. It aims to find out whether giving it earlier or later in your visit works better and is safer.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial tests a special painkiller called sufentanil given as a nasal spray to children with sickle cell disease who are having a severe pain crisis. It aims to see if this nasal spray works better or as well as usual pain treatment to quickly reduce pain in the emergency room.
Hear when a new Vaso-Occlusive Pain Episode in Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.